Free · No account required · Powered by AI across the world's largest grants + funders database
Currently focused on US federal, state, and foundation grants.
Free · No account required · Powered by AI across the world's largest grants + funders database
Currently focused on US federal, state, and foundation grants.
Catalyst to Independence Award is sponsored by Additional Ventures Foundation. A transition award designed to support exceptional early career scientists during the final years of their mentored postdoctoral research position through their transition to an independent tenure-track faculty position. The program provides financial support, mentorship, and professional development to investigators pursuing research relevant to single ventricle heart disease.
Geographic focus: Global (with preference for US-based institutions)
Focus areas: Single Ventricle Heart Disease, Genetics, Cardiovascular Development, Tissue Engineering, Computational Modeling
Official opportunity description and requirements excerpt:
Additional Ventures – Together, we can cure single ventricle. For Patients and Families Together, we can cure single ventricle. Additional Ventures’ mission is to cure single ventricle heart disease through transformative research and strategic investments that revolutionize treatment and care. We spur catalytic collaboration within the single ventricle community, facilitate faster and better science through agile approaches to research funding, and ensure researchers have the resources needed to drive toward a cure — all with intentionality, optimism, and urgency. Learn how we’re fueling transformative single ventricle research For Patients and Families Explore our approach to improving quality of life for single ventricle patients through research Since 2020, Additional Ventures has been embedded within the biomedical research community, optimizing and accelerating high-quality single ventricle research. We are inspired by progress made to date… in single ventricle research funding studies aimed at understanding and curing single ventricle research publications from Additional Ventures funded researchers …and motivated by scientific and clinical advancements actively taking shape. Mark Your Calendars: SVIM Returns in 2026! Join us October 7-9, 2026 in Denver, CO for the Single Ventricle Investigator Meeting, the premier convening dedicated entirely to advancing discovery and collaboration in single ventricle heart disease. A New Era for Single Ventricle Science: Introducing the Translational Accelerator Additional Ventures has launched the Translational Accelerator, a groundbreaking program that will enable the next phase of progress in single… Open Now! Single Ventricle Research Fund The sixth cycle of the Single Ventricle Research Fund (SVRF), Additional Ventures’ flagship research award program, is now open! Sixteen Research Teams Selected for 2025 Single Ventricle Research Fund Award The sixteen research teams awarded through the 2025 Single Ventricle Research Fund (SVRF) — which includes thirteen independent investigators and… A New Era for Single Ventricle Science: Introducing the Translational Accelerator Additional Ventures has launched the Translational Accelerator, a groundbreaking program that will enable the next phase of progress in single… Open Now! Single Ventricle Research Fund The sixth cycle of the Single Ventricle Research Fund (SVRF), Additional Ventures’ flagship research award program, is now open! Sixteen Research Teams Selected for 2025 Single Ventricle Research Fund Award The sixteen research teams awarded through the 2025 Single Ventricle Research Fund (SVRF) — which includes thirteen independent investigators and… Keep up with our progress Join our email list for timely updates on research progress, programs, and events For Patients and Families
Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Additional Ventures – Together, we can cure single ventricle. For Patients and Families Together, we can cure single ventricle. Additional Ventures’ mission is to cure single ventricle heart disease through transformative research and strategic investments that revolutionize treatment and care.
We spur catalytic collaboration within the single ventricle community, facilitate faster and better science through agile approaches to research funding, and ensure researchers have the resources needed to drive toward a cure — all with intentionality, optimism, and urgency.
Learn how we’re fueling transformative single ventricle research For Patients and Families Explore our approach to improving quality of life for single ventricle patients through research Since 2020, Additional Ventures has been embedded within the biomedical research community, optimizing and accelerating high-quality single ventricle research.
We are inspired by progress made to date… in single ventricle research funding studies aimed at understanding and curing single ventricle research publications from Additional Ventures funded researchers …and motivated by scientific and clinical advancements actively taking shape. Mark Your Calendars: SVIM Returns in 2026!
Join us October 7-9, 2026 in Denver, CO for the Single Ventricle Investigator Meeting, the premier convening dedicated entirely to advancing discovery and collaboration in single ventricle heart disease.
A New Era for Single Ventricle Science: Introducing the Translational Accelerator Additional Ventures has launched the Translational Accelerator, a groundbreaking program that will enable the next phase of progress in single… Open Now! Single Ventricle Research Fund The sixth cycle of the Single Ventricle Research Fund (SVRF), Additional Ventures’ flagship research award program, is now open!
Sixteen Research Teams Selected for 2025 Single Ventricle Research Fund Award The sixteen research teams awarded through the 2025 Single Ventricle Research Fund (SVRF) — which includes thirteen independent investigators and… A New Era for Single Ventricle Science: Introducing the Translational Accelerator Additional Ventures has launched the Translational Accelerator, a groundbreaking program that will enable the next phase of progress in single… Open Now!
Based on current listing details, eligibility includes: Early career scientists (e.g., postdoctoral fellows, clinical research fellows, or instructors) in mentored, non-independent positions who hold a PhD, MD, DO, or equivalent. Applicants must have earned their doctoral degree more than one year prior to the application and held their current role for at least one year. Applicants should confirm final requirements in the official notice before submission.
Current published award information indicates Up to $1,000,000 over 5 years Always verify allowable costs, matching requirements, and funding caps directly in the sponsor documentation.
The current target date is March 16, 2026. Build your timeline backwards from this date to cover registrations, approvals, attachments, and final submission checks.
View foundation profile, grantmaking history, financials, and key people.
View Foundation ProfileApplication snapshot: target deadline March 16, 2026; published funding information Up to $1,000,000 over 5 years; eligibility guidance Early career scientists (e.g., postdoctoral fellows, clinical research fellows, or instructors) in mentored, non-independent positions who hold a PhD, MD, DO, or equivalent. Applicants must have earned their doctoral degree more than one year prior to the application and held their current role for at least one year.
Use the official notice and source links for final requirements, attachment checklists, allowable costs, and submission instructions before applying.
Single Ventricle Research Fund The sixth cycle of the Single Ventricle Research Fund (SVRF), Additional Ventures’ flagship research award program, is now open!
Sixteen Research Teams Selected for 2025 Single Ventricle Research Fund Award The sixteen research teams awarded through the 2025 Single Ventricle Research Fund (SVRF) — which includes thirteen independent investigators and… Keep up with our progress Join our email list for timely updates on research progress, programs, and events For Patients and Families
© 2026 Granted AI